Searched for
PHARMACEUTICAL INDUSTRY
India launches anti-dumping probes into five Chinese products after domestic industry complaintsThe Directorate General for Trade Remedies in India is probing complaints from domestic producers about six imported products from China. A...- Indian companies must invest in R&D, move from generics to innovation-led industry: Pharma leadersIndian pharmaceutical leaders emphasize the need for investment in innovation to transition from generics to innovative products. They high...
- Indonesia's mandatory halal rules may raise compliance burden for Indian exporters: GTRIOn October 17, Indonesia’s new halal-certification policies will take effect, significantly influencing Indian exporters across sectors. En...
- 5 stocks with consistent score improvement and upside potential of up to 32% in 1 year, according to analystsFor the next few weeks, the markets will readjust as business updates, which have started to arrive, and the Q2 earnings numbers roll in. C...
- AMFI reshuffle: NSE may get largecap status, SBI Fund Management may become midcap in H1 CY27Nuvama expects NSE to enter the largecap category and SBI Funds Management to become a midcap in AMFI’s H1 CY27 reshuffle. Bosch, Siemens E...
- As ‘world architecture’ changes, Jaishankar calls for middle powers to pool resourcesExternal Affairs Minister S Jaishankar called on emerging and middle powers to pool diplomatic, economic and technological resources as glo...
- GVC integration, supply chain resilience, FTAs key to boost exports, high-end manufacturing: Deloitte IndiaIndia needs deeper integration into global value chains, lower logistics costs and better use of free trade agreements to boost exports and...
- China launches anti-dumping probe into chemical compound p-nitrotoluene from the EUChina has launched an anti-dumping investigation regarding p-nitrotoluene imports from the European Union due to trade tensions. This inves...
- China initiates anti-dumping investigation into p-nitrotoluene from EUChina's Commerce Ministry has launched an anti-dumping investigation concerning p-nitrotoluene imports from the European Union. This decisi...
- India, Australia aim to expedite CECA, review ECTA progress to maximize duty-free access for Indian exportersIndia and Australia are looking to accelerate negotiations on their Comprehensive Economic Cooperation Agreement, with Commerce Minister Pi...
- Inox Air Products files IPO papers; issue size not disclosedInox Air Products has unveiled a draft red herring prospectus as it seeks to raise substantial funds through an initial public offering. As...
- Output, wages, GVA... manufacturing sector is on a roll: GVA grows 9.6% to Rs 26.9 lakh crore; sector adds 1.4 mn workersIndia’s formal manufacturing sector recorded broad-based growth in 2024-25, with GVA rising 9.6% to ₹26.9 lakh crore and industrial output ...
- India’s industrial jobs cross 2 cr mark in 2024-25India's industrial workforce increased to over 2 crore in 2024-25, driven largely by the manufacturing sector. The registered manufacturing...
- Iran's medicines soar in price as US blockade, sanctions squeeze pharmaceutical suppliesMedication prices in Iran have surged drastically due to US sanctions and ongoing conflict, creating significant hardships. Families are st...
- Sun Pharma plans $1 billion local debt sale for loan takeout, sources saySun Pharma is planning to raise about Rs 10,000 crore through rupee-denominated bonds to partly refinance a bridge loan used for its Organo...
- Anupam Rasayan completes Bliss GVS deal, targets Rs 4,000-crore integrated platformAnupam Rasayan India Limited has finalised its acquisition of a controlling interest in Bliss GVS Pharma, marking a strategic expansion int...
- Steamhouse India wins Rs 311 crore EPC mandate for 300 TPH steam project in Himachal PradeshSteamhouse India Ltd has secured a Rs 311 crore EPC mandate for a 300 TPH common steam and co-generation power plant at the Bulk Drug Park ...
- Rs 78,400 vs Rs 7,750 medicine: Novartis, Eli Lilly oppose bid to cut breast cancer drug prices in IndiaNovartis and Eli Lilly have opposed a Kerala High Court petition seeking government intervention to make two breast cancer drugs cheaper, d...
- Jagsonpal Pharma to acquire Group Pharma’s wellness portfolioJagsonpal Pharmaceuticals has signed a business transfer agreement to acquire the wellness portfolio of Group Pharmaceuticals. The acquisit...
- European pharma chiefs warn region risks losing ground to America, ChinaDrugmakers for months have been warning they could curtail investments and delay the release of new medications in Europe, widening a dispa...
Load More
